Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

467
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
467
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Passive Diffusion: Overview and Kinetics01:17

Passive Diffusion: Overview and Kinetics

348
Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
348
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

316
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
316
Facilitated Diffusion01:16

Facilitated Diffusion

262
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
262
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.6K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

ChatMDV: Reducing Technical Barriers in Bioinformatics Analysis using Large Language Models.

GigaScience·2026
Same author

ANARCII enables alignment-free antigen receptor numbering using a generalised language model.

Communications biology·2026
Same author

iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria.

Nature metabolism·2026
Same author

Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.

mAbs·2026
Same author

LICHEN enables light-chain immunoglobulin sequence generation conditioned on the heavy chain and experimental needs.

Communications biology·2026
Same author

Characterising nanobody developability to improve therapeutic design using the Therapeutic Nanobody Profiler.

Communications biology·2026
Same journal

QSAR in the Browser: An Interactive Cheminformatics Web Application.

Journal of chemical information and modeling·2026
Same journal

FoldDoF: Utilizing the Primary Degrees of Freedom of Protein Backbone for Geometric Modeling and Generation.

Journal of chemical information and modeling·2026
Same journal

Derisking Affinity Optimization for Macrocycles and Cyclic Peptides: High-Precision Free Energy Simulations across Five Diverse Targets.

Journal of chemical information and modeling·2026
Same journal

An End-User Audit of Reproducibility, Data Leakage, and Overfitting of the Top-Ranked ADMET Prediction Models in TDC Leaderboards.

Journal of chemical information and modeling·2026
Same journal

PFASGroups: An Open-Source Framework for Automated Identification, Structural Classification, and Prioritization of Per- and Polyfluoroalkyl Substances.

Journal of chemical information and modeling·2026
Same journal

DeepKbhb: Context-Aware Prediction of Human Lysine β-Hydroxybutyrylation Sites.

Journal of chemical information and modeling·2026
查看所有相关文章

相关实验视频

MolSnapper:基于结构的药物设计的调节扩散.

Yael Ziv1, Fergus Imrie1, Brian Marsden2

  • 1Department of Statistics, University of Oxford, St Giles, Oxford OX1 3LB, U.K.

Journal of chemical information and modeling
|April 18, 2025
PubMed
概括
此摘要是机器生成的。

MolSnapper 将专家知识集成到药物设计的生成模型中. 这种新的工具通过创建更适合目标结合位点的分子来增强分子设计,从而产生更有效的结果.

相关实验视频

科学领域:

  • 计算化学是一种计算化学.
  • 药品化学 药品化学 是一个
  • 药物发现 药物发现

背景情况:

  • 生成模型显示出分子设计的前景,但在目标结合方面存在困难.
  • 控制分子设计和结合先前的知识对于药物开发至关重要.
  • 将分子定制为特定的结合部位仍然是基于结构的药物设计的一个重大挑战.

研究的目的:

  • 介绍MolSnapper,这是一个基于结构的药物设计的新工具.
  • 使用专家知识 (3D药理) 实现扩散模型的调节.
  • 提高具有高结合亲和力和特异性的分子的生成.

主要方法:

  • 开发了MolSnapper,以将3D药融入扩散模型.
  • 使用专家定义的药理制约条件的条件生成模型.
  • 在交叉对接和绑定MOAD数据集上验证了方法.

主要成果:

  • 摩尔Snapper可以生成更适合特定结合点的分子.
  • 达到与原始分子具有很高的结构和化学相似性.
  • 与替代方法相比,生产了大约两倍的有效分子.

结论:

  • MolSnapper有效地将专家知识集成到基于结构的药物设计中.
  • 该工具增强了生成高质量的候选药物的能力.
  • MolSnapper在产生有效分子用于药物发现方面提供了显著的改进.